Dr. Anna Kovilakath presents her Research at the Prestigious 2025 FASEB Conference in Ireland.
By: Chanelle Kamga and Usha Mahawar, PhD
Department of CMGM
Email: Kamganguekacb@vcu.edu
Date: October 6, 2025
Dr. Anna Kovilakath, a dedicated postdoctoral researcher working under the guidance of Dr. Salloum and Dr. Cowart in their innovative lab, recently participated in the prestigious 2025 FASEB Lipid Mediators: Advancements and Approaches Conference. This notable event took place in Malahide, Ireland, from September 7 to 11, gathering experts and enthusiasts from around the globe to discuss the latest advancements in lipid biology and its implications for health and disease. During this gathering, Dr. Kovilakath delivered an impactful oral presentation entitled “Atypical Sphingolipids Contribute to Aromatase Inhibitor-Accelerated Atherosclerosis.” In her talk, she unveiled groundbreaking findings that shed light on the intricate role atypical sphingolipids play in the progression of atherosclerosis, particularly in patients undergoing treatment with aromatase inhibitors. This area of research is crucial, as it explores the intersection of lipid metabolism and cardiovascular health, opening new avenues for understanding how certain therapies might influence cardiovascular risks.
Dr. Kovilakath's presentation stimulated lively discussions among attendees, triggering a wealth of questions and exchanges about the translational implications of her research. Her work not only highlights the importance of lipid biology but also underscores the need for further investigation into the cardiovascular impact of various treatments in clinical settings. Her representation at such an esteemed conference reflects not only her commitment to advancing scientific knowledge but also the high caliber of research being conducted in her lab.
We are incredibly proud of Dr. Anna for showcasing her significant findings on an international stage. We congratulate her on a successful presentation and the enriching conference experience that has undoubtedly contributed to her ongoing professional development in the field. This achievement is a testament to her hard work and dedication, and we look forward to seeing how her research continues to evolve and influence the field of cardiovascular disease and lipid metabolism.